C07K 14/43545
From caenorhabditis
Official title: {from Caenorhabditis}
C07K14/43545 (From caenorhabditis) appears on 65 US grants and 86 published applications in this corpus.
Search patents in C07K- Granted patents
- 65
- Published applications
- 86
- Assignees
- 64
- Inventors
- 231
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 3 |
| 2003 | 5 | 13 |
| 2004 | 4 | 10 |
| 2005 | 3 | 7 |
| 2006 | 4 | 6 |
| 2007 | 4 | 7 |
| 2008 | 5 | 9 |
| 2009 | 1 | 1 |
| 2010 | 6 | 4 |
| 2011 | 0 | 1 |
| 2012 | 1 | 2 |
| 2013 | 2 | 5 |
| 2014 | 0 | 0 |
| 2015 | 0 | 5 |
| 2016 | 3 | 1 |
| 2017 | 4 | 6 |
| 2018 | 1 | 0 |
| 2019 | 4 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 3 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Reagents and methods for detecting protein lysine lactylation16 Sep 2025US 12,416,639 B2Jingjie PTM BioLab (Hangzhou) Co., Ltd.
- Compositions and methods for improved gene editing16 Jan 2024US 11,873,487 B2University of Massachusetts
- Reagents and methods for detecting protein lysine 3-hydroxybutyrylation12 Jul 2022US 11,385,240 B2Ptm Bio LLC
- Sugar transporters2 Apr 2019US 10,246,721 B2Carnegie Institution of Washington
- Peptides for the specific binding of RNA targets19 Mar 2019US 10,233,218 B2The University of Western Australia
- Compositions and methods for improved gene editing20 Apr 2023US 2023/0117203 A1University of Massachusetts
- Compositions and methods for improved gene editing3 Nov 2022US 2022/0348912 A1University of Massachusetts
- Production and uses of artifical histone h1 for analyzing, diagnosing, treating, and/or preventing senescence26 May 2022US 2022/0162274 A1
- Reagents and methods for detecting protein lysine lactylation24 Mar 2022US 2022/0091129 A1Jingjie PTM BioLab (Hangzhou) Co., Ltd.
- Screening for agents that target the actin cytoskeleton using c. elegans exposed to heat shock12 Mar 2020US 2020/0080991 A1Rutgers, The State University of New Jersey
Most cited
By later US patents
- 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor42US 7,411,054 B2Millennium Pharmaceuticals, Inc. · 2008
- RNA interference pathway genes as tools for targeted genetic interference36US 7,282,564 B2Carnegie Institute of Washington · 2007
- Synthetic peptides and vaccines comprising same26US 6,174,528 B1Biotech Australia PTY Limited · 2001
- C. elegans deletion mutants20US 6,278,039 B1Axys Pharmaceuticals, Inc. · 2001
- DNA sequences involved in neuronal degeneration, multicellular organisms containing same and uses thereof11US 5,196,333 AThe Trustees of Columbia University · 1993